WallStreetZen

NYSE: ABBV
AbbVie Inc Earnings & Revenue

ABBV past earnings growth

How has ABBV's earnings growth performed historically?
Company
-50.79%
Industry
14.79%
Market
102.72%
ABBV's earnings have grown slower (-3.59% per year) than the US Drug Manufacturers - General industry average (14.81%)
Performance
ABBV's earnings have grown slower (-3.59% per year) than the US market average (27.52%)
Performance
ABBV's earnings growth is slowing down - its growth over the last year (-50.79%) is below its 5-year compound annual rate (-3.59%)
Performance

ABBV past revenue growth

How has ABBV's revenue growth performed historically?
Company
47.39%
Industry
13.32%
Market
36.32%
ABBV's revenue has grown faster (16.12% per year) than the US Drug Manufacturers - General industry average (5.13%)
Performance
ABBV's revenue has grown slower (16.12% per year) than the US market average (17.66%)
Performance
ABBV's revenue growth is accelerating - its growth over the last year (47.39%) is above its 5-year compound annual rate (16.12%)
Performance

ABBV earnings and revenue history

Current Revenue
$50.2B
Current Earnings
$5.2B
Current Profit Margin
10.3%

ABBV Return on equity

Current Company
36.4%
Current Industry
31.9%
Current Market
30.7%
ABBV's Return on Equity (36.4%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

ABBV Return on assets

Current Company
3.4%
Current Industry
6.8%
Current Market
6.4%
ABBV is generating lower Return on Assets (3.4%) than the US Drug Manufacturers - General industry average (7.27%)
Performance

ABBV Return on capital employed

Current Company
5.6%
Current Industry
11.3%
ABBV's ability to generate Return on Capital (5.6%) has decreased compared to 3 years ago (18.07%)
Performance

AbbVie Earnings & Revenue FAQ

What were ABBV's earnings last quarter?

On Apr 30, 2021, AbbVie (NYSE: ABBV) reported Q1 2021 earnings per share (EPS) of $2.00, up 0.99% year over year. Total AbbVie earnings for the quarter were $3.55 billion. In the same quarter last year, AbbVie's earnings per share (EPS) was $2.02.

What was ABBV's earnings growth in the past year?

As of Q3 2021, AbbVie's earnings has grown -50.79% year over year. This is 65.59 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 14.79%. AbbVie's earnings in the past year totalled $5.16 billion.

What was ABBV's revenue last quarter?

On Apr 30, 2021, AbbVie (NYSE: ABBV) reported Q1 2021 revenue of $13.01 billion up 50.95% year over year. In the same quarter last year, AbbVie's revenue was $8.62 billion.

What was ABBV's revenue growth in the past year?

As of Q3 2021, AbbVie's revenue has grown 47.39% year over year. This is 34.06 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 13.32%. AbbVie's revenue in the past year totalled $50.20 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.